Bellevue Life Sciences Acquisition (OSRH) EBITDA (2022 - 2026)
Bellevue Life Sciences Acquisition (OSRH) EBITDA from Mar 31, 2022 to Mar 31, 2026. The TTM Bellevue Life Sciences Acquisition (OSRH) EBITDA is -$19M. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual EBITDA
Quarterly EBITDA
Bellevue Life Sciences Acquisition (OSRH) EBITDA CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | +68.55% |
Annual EBITDA change of Bellevue Life Sciences Acquisition (OSRH)
| Year | EBITDA | Change |
|---|---|---|
| 2026 | -$3.66M | -80.03% |
| 2025 | -$18M | +56.80% |
| 2024 | -$12M | -1343.62% |
| 2023 | $940K | -2450.00% |
| 2022 | -$40K | N/A |
| 2021 | $0 | N/A |